Home › Trial NCT01091792
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
- Trial IDNCT01091792
- StatusCompleted
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorDartmouth-Hitchcock Medical Center
- Enrollment13
- Start date2010-03
- ConditionsGlioblastoma Multiforme
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.